Ekf Diagnostics Holding PLC’s “Buy” Rating Reaffirmed at Canaccord Genuity (EKF)
Ekf Diagnostics Holding PLC (LON:EKF)‘s stock had its “buy” rating reiterated by research analysts at Canaccord Genuity in a report released on Tuesday. They currently have a GBX 48 ($0.82) target price on the stock. Canaccord Genuity’s price target would indicate a potential upside of 77.25% from the company’s current price.
Shares of Ekf Diagnostics Holding PLC (LON:EKF) traded down 0.93% during mid-day trading on Tuesday, hitting GBX 26.50. 72,781 shares of the company’s stock traded hands. Ekf Diagnostics Holding PLC has a 52-week low of GBX 23.60 and a 52-week high of GBX 43.00. The stock’s 50-day moving average is GBX 25.80 and its 200-day moving average is GBX 32.57.
A number of other firms have also recently commented on EKF. Analysts at FinnCap reiterated a “buy” rating on shares of Ekf Diagnostics Holding PLC in a research note on Tuesday. They now have a GBX 38 ($0.65) price target on the stock. Separately, analysts at N+1 Singer reiterated a “buy” rating on shares of Ekf Diagnostics Holding PLC in a research note on Wednesday, June 18th. They now have a GBX 38 ($0.65) price target on the stock. Five investment analysts have rated the stock with a buy rating, The stock presently has an average rating of “Buy” and an average target price of GBX 40.60 ($0.70).
EKF Diagnostics Holdings Plc designs, develops, manufactures and sells diagnostic instruments, reagents and certain ancillary products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.